Abbott Laboratories ABT reported its Q2 earnings results on Wednesday, July 20, 2022 at 07:30 AM.
Here’s what investors need to know about the announcement.
Earnings
Abbott Laboratories beat estimated earnings by 27.68%, reporting an EPS of $1.43 versus an estimate of $1.12.
Revenue was up $1.03 billion from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.26 which was followed by a 0.6% increase in the share price the next day.
Here’s a look at Abbott Laboratories’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | 1.47 | 1.21 | 0.94 | 1.02 |
| EPS Actual | 1.73 | 1.32 | 1.40 | 1.17 |
| Revenue Estimate | 11.02B | 10.71B | 9.54B | 9.69B |
| Revenue Actual | 11.89B | 11.47B | 10.93B | 10.22B |
To track all earnings releases for Abbott Laboratories visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Image and article originally from www.benzinga.com. Read the original article here.